Chandan Diagnostic

Lucknow, India Founded: 1991 • Age: 35 yrs Listed
Radiology and pathology laboratory centers are operated as a chain.
Request Access
Report Incorrect Data
Page last updated

About Chandan Diagnostic

Chandan Diagnostic is a publicly listed company based in Lucknow (India) founded in 1991. Radiology and pathology laboratory centers are operated as a chain. Its website chandandiagnostic.com draws about 11 thousand monthly visits. Its Indian entity Chandan Healthcare Limited reported revenue of ₹281 Cr. Chandan Diagnostic offers products and services including Diagnostic Tests, Home Sample Collection, and Mobile App Booking. Its focus areas include Clinical Laboratory Chains and Diversified. Its competitors include Thyrocare, Vijaya Diagnostic Centre and Suraksha Diagnostics; 2 of its 3 listed competitors have raised funding.

Company details

Chandan Diagnostic was established in 1991 in Lucknow, India, within the healthcare sector. A network of laboratory centers is maintained, focusing on radiology and pathology services. Diagnostic testing and imaging procedures are provided to patients across multiple locations in the region. Operations are centered on clinical laboratory functions, supporting medical diagnostics for local communities. The domain chandandiagnostic.com is utilized for online presence and information dissemination.

Operational Areas
Healthcare → Diagnostics Laboratories
Key Metrics
  • Market Cap
    ₹560 Cr

    CHANDAN-SM · NSE

  • Share Price
    ₹218.60

    -4.54% today

  • Revenue
    ₹276 Cr

    FY 2025-26 · +20.1% YoY

  • EBITDA
    ₹57.21 Cr

    Margin 20.7%

  • Net Profit
    ₹19.40 Cr

    FY 2025-26 · -12.5% YoY

  • P/E (TTM)
    21.3x

    P/B 3.3x

Products & Services of Chandan Diagnostic

Chandan Diagnostic offers a comprehensive portfolio of products and services, including Diagnostic Tests, Home Sample Collection, and Mobile App Booking.

Diagnostic Tests
Medical Services

Comprehensive tests for accurate health diagnosis and monitoring.

Home Sample Collection
Convenience Services

Doorstep service for safe and professional sample collection.

Mobile App Booking
Digital Services

App for scheduling tests and accessing reports easily.

Apps and channels of Chandan Diagnostic

Chandan Diagnostic publishes 1 mobile app with over 100K+ downloads; its YouTube channel Chandan Diagnostic has 193 subscribers.

Chandan 24x7
Google Play Medical Everyone Free 100K+ downloads
Developer: Chandan Pharmacy Limited
View on Google Play
Chandan Diagnostic
YouTube 193 subscribers Howto & Style
Open channel

Board of directors of Chandan Healthcare Limited (Chandan Diagnostic)

Chandan Healthcare Limited is the primary company behind Chandan Diagnostic. The board of Chandan Healthcare Limited currently have 7 directors; the longest-serving is Amar Singh, appointed in 2003. 22 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amar Singh
DIN 01096328
Managing Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Asmita Singh
DIN 01098055
Managing Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Vinay Lamba
DIN 01220153
Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Amit Gupta
DIN 00583538
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Vinod Jain
DIN 10701178
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Brahma Nand Bhartiya
DIN 10729411
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Sanjay Srivastava
DIN 11927967
Director07 Sep 20261 moChandan Healthcare Limited

IPO & Listings of Chandan Diagnostic

Chandan Diagnostic is a publicly listed company on the NSE with ticker symbol CHANDAN in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date17 Feb 2025
  • Listed onNSE: CHANDAN
  • Listed entityCHANDAN HEALTHCARE LIMITED
  • Exchange sectorHealth services
  • ISININE0B2N01016
  • Share price₹237.85 (+2.28% on the day) · 2026-10-14
  • Market capitalisation₹569 Cr
  • Price to earnings30.1
  • Volume (last session)15,200

Financials of Chandan Diagnostic

Exchange-reported figures of Chandan Healthcare Limited, the listed company behind Chandan Diagnostic (NSE: CHANDAN-SM).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹276 Cr
+20.1% YoY
EBITDA
₹57.21 Cr
+38.4% YoY
Profit After Tax
₹19.40 Cr
-12.5% YoY
Net Worth
₹171 Cr
+39.5% YoY
Total Assets
₹235 Cr
+31.8% YoY
Total Debt
₹53.75 Cr
+11.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue276230177137120
Revenue growth+20.1%+30.3%+29.0%+14.5%-
EBITDA57.2141.3326.399.372.24
EBITDA margin+20.7%+18.0%+14.9%+6.8%+1.9%
Profit before tax32.2432.0621.465.00(1.08)
Net profit19.4022.1716.273.36(1.13)
Net profit margin+7.0%+9.6%+9.2%+2.5%-1.0%
EPS (₹)7.729.078.141.68(0.55)
Balance sheet
Total assets23517882.5953.6145.22
Net worth17112341.1627.3023.93
Total debt53.7548.1635.9121.3616.58
Cash & bank3.586.213.902.041.58
Net working capital10063.6227.257.557.93
Cash flow
Cash from operations16.17(2.75)1.124.506.10
Cash from investing(39.90)(62.04)(14.83)(6.49)(10.75)
Cash from financing21.1067.1115.572.463.48
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue80.8575.5865.0167.9067.9062.6554.64
Revenue growth (YoY)+19.1%+20.6%+19.0%----
Other income1.411.850.770.840.872.420.17
EBITDA19.5711.479.6214.1513.8710.238.89
EBITDA margin+24.2%+15.2%+14.8%+20.8%+20.4%+16.3%+16.3%
Depreciation4.473.742.402.463.752.701.35
Interest4.831.781.281.401.371.301.09
Profit before tax11.687.806.7111.139.628.656.62
Tax3.782.861.672.873.432.562.00
Net profit7.904.945.048.266.196.094.62
EPS (₹)2.591.951.863.192.302.640.00
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue15712999.8775.8371.6055.9566.56
Revenue growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
EBITDA43.7236.8325.439.312.734.946.21
EBITDA margin+27.9%+28.5%+25.5%+12.3%+3.8%+8.8%+9.3%
Profit before tax33.9128.1520.965.27(0.71)1.472.35
Net profit27.3820.7616.014.05(1.44)0.811.43
Net profit margin+17.5%+16.1%+16.0%+5.3%-2.0%+1.5%+2.2%
EPS (₹)10.088.508.012.02(0.69)0.410.71
Balance sheet
Total assets21115772.5945.2937.9938.7038.62
Net worth16712140.6726.6522.6124.9423.96
Total debt39.0233.2029.0816.5815.3813.7514.66
Cash & bank3.146.030.531.541.962.442.12
Net working capital78.1044.5913.66(3.69)(1.12)7.66(1.87)
Cash flow
Cash from operations24.166.385.854.747.49(6.63)-
Cash from investing(49.85)(60.86)(15.36)(2.20)(9.52)7.45-
Cash from financing22.7959.998.51(2.00)(1.83)(0.50)-
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue48.6744.7735.7038.0935.8837.0529.52
Revenue growth (YoY)+35.7%+20.8%+20.9%----
Other income1.092.000.680.730.751.900.05
Total expenses31.5634.1127.7525.5324.2826.6722.13
EBITDA17.1110.667.9512.5611.6010.387.39
EBITDA margin+35.2%+23.8%+22.3%+33.0%+32.3%+28.0%+25.0%
Depreciation4.182.342.372.402.922.421.34
Interest4.061.370.941.060.990.980.86
Profit before tax9.968.955.329.838.448.885.24
Tax3.242.131.352.533.062.471.64

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue80.8575.5865.0167.9067.9062.6554.64
Revenue growth (YoY)+19.1%+20.6%+19.0%----
Other income1.411.850.770.840.872.420.17
EBITDA19.5711.479.6214.1513.8710.238.89
EBITDA margin+24.2%+15.2%+14.8%+20.8%+20.4%+16.3%+16.3%
Depreciation4.473.742.402.463.752.701.35
Interest4.831.781.281.401.371.301.09
Profit before tax11.687.806.7111.139.628.656.62
Tax3.782.861.672.873.432.562.00
Net profit7.904.945.048.266.196.094.62
EPS (₹)2.591.951.863.192.302.640.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue276230177137120
Revenue growth+20.1%+30.3%+29.0%+14.5%-
Other income4.392.051.220.140.35
Total expenses219189150128117
Employee cost0.0038.8635.4225.4918.73
EBITDA57.2141.3326.399.372.24
EBITDA margin+20.7%+18.0%+14.9%+6.8%+1.9%
Depreciation14.936.743.402.091.96
Interest14.434.582.752.421.71
Profit before tax32.2432.0621.465.00(1.08)
Tax11.968.555.111.420.03
Net profit19.4022.1716.273.36(1.13)
Net profit margin+7.0%+9.6%+9.2%+2.5%-1.0%
EPS (₹)7.729.078.141.68(0.55)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital24.4524.4520.0020.0020.00
Reserves & surplus14598.1521.167.303.93
Shareholders' funds (net worth)17112341.1627.3023.93
Minority interest5.303.812.462.762.54
Secured loans53.7548.1635.9121.3616.56
Unsecured loans0.000.000.000.000.02
Total debt53.7548.1635.9121.3616.58
Total liabilities23517882.5953.6145.22
Assets
Gross block15411984.2764.9359.65
Net block10176.3548.4932.5529.36
Capital work in progress11.994.100.000.000.00
Investments19.9633.153.387.406.11
Inventories34.0831.7018.319.876.56
Sundry debtors86.4047.2628.6123.6928.70
Cash & bank balances3.586.213.902.041.58
Loans & advances28.889.8010.5815.096.32
Total current assets15394.9761.4050.6943.16
Total current liabilities52.8331.3534.1543.1435.23
Net working capital10063.6227.257.557.93
Total assets23517882.5953.6145.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash6.213.902.041.582.75
Net cash from operating activities16.17(2.75)1.124.506.10
Net cash from investing activities(39.90)(62.04)(14.83)(6.49)(10.75)
Net cash from financing activities21.1067.1115.572.463.48
Net change in cash(2.63)2.311.860.47(1.17)
Closing cash3.586.213.902.041.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+20.1%+30.3%+29.0%+14.5%-
EBITDA growth+38.4%+56.6%+181.6%+318.3%-
PBT growth+0.6%+49.4%+329.2%+9998.0%+9997.0%
Net income growth-12.5%+36.3%+384.2%+397.4%-
Revenue CAGR (3Y)+26.4%+24.4%---
EBITDA CAGR (3Y)+82.8%+164.2%---
Profitability & leverage
Net income margin+7.3%+10.2%+9.3%+2.6%-0.9%
Return on capital employed-+28.8%+37.0%+15.9%+1.5%
Return on net worth-+28.7%+47.8%+14.0%-4.6%
Debt / equity-0.510.840.740.69
Long-term debt / equity-0.210.290.280.00
Interest cover34.1313.2411.9633.24610.71
Efficiency & per share
Fixed asset turnover-2.272.372.202.00
Inventory turnover-9.2012.5316.6618.23
Debtors turnover-6.116.755.234.17
EPS (₹)7.729.078.141.68(0.55)
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)0.0050.1420.5813.6511.97
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue48.6744.7735.7038.0935.8837.0529.52
Revenue growth (YoY)+35.7%+20.8%+20.9%----
Other income1.092.000.680.730.751.900.05
Total expenses31.5634.1127.7525.5324.2826.6722.13
EBITDA17.1110.667.9512.5611.6010.387.39
EBITDA margin+35.2%+23.8%+22.3%+33.0%+32.3%+28.0%+25.0%
Depreciation4.182.342.372.402.922.421.34
Interest4.061.370.941.060.990.980.86
Profit before tax9.968.955.329.838.448.885.24
Tax3.242.131.352.533.062.471.64
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue15712999.8775.8371.6055.9566.56
Revenue growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
Other income4.131.311.000.090.200.080.23
Total expenses11392.3374.4466.5268.8751.0160.35
Employee cost0.0033.3930.4619.6714.2711.2214.74
EBITDA43.7236.8325.439.312.734.946.21
EBITDA margin+27.9%+28.5%+25.5%+12.3%+3.8%+8.8%+9.3%
Depreciation9.516.423.362.051.951.542.31
Interest4.433.572.112.081.692.011.78
Profit before tax33.9128.1520.965.27(0.71)1.472.35
Tax8.567.394.951.220.660.660.92
Net profit27.3820.7616.014.05(1.44)0.811.43
Net profit margin+17.5%+16.1%+16.0%+5.3%-2.0%+1.5%+2.2%
EPS (₹)10.088.508.012.02(0.69)0.410.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital24.4524.4520.0020.0020.0020.0020.00
Reserves & surplus14296.2620.676.652.614.943.96
Shareholders' funds (net worth)16712140.6726.6522.6124.9423.96
Secured loans39.0233.2029.0815.3115.3713.4912.12
Unsecured loans0.000.000.001.270.010.262.54
Total debt39.0233.2029.0816.5815.3813.7514.66
Total liabilities21115772.5945.2937.9938.7038.62
Assets
Gross block14511177.1158.8352.2346.7845.40
Net block95.7471.4843.5327.7324.8120.1620.32
Capital work in progress11.904.100.000.000.000.000.00
Investments24.1936.5812.5515.4114.1211.0319.93
Inventories16.3917.286.520.361.232.694.69
Sundry debtors44.2231.3121.8615.9010.4411.669.83
Cash & bank balances3.146.030.531.541.962.442.12
Loans & advances33.888.063.821.425.587.191.03
Total current assets97.6362.6832.7319.2219.2123.9817.67
Total current liabilities19.5318.0919.0722.9120.3316.3219.54
Net working capital78.1044.5913.66(3.69)(1.12)7.66(1.87)
Total assets21115772.5945.2937.9938.7038.62
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.030.531.541.005.822.12-
Net cash from operating activities24.166.385.854.747.49(6.63)-
Net cash from investing activities(49.85)(60.86)(15.36)(2.20)(9.52)7.45-
Net cash from financing activities22.7959.998.51(2.00)(1.83)(0.50)-
Net change in cash(2.90)5.50(1.01)0.54(3.85)0.32-
Closing cash3.146.030.531.541.962.44-
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
EBITDA growth+18.7%+44.8%+173.2%+241.0%-44.7%-20.5%-
PBT growth+20.5%+34.3%+297.7%+9998.0%--37.5%+9997.0%
Net income growth+31.9%+29.7%+295.3%+381.3%-277.8%-43.4%-
Revenue CAGR (3Y)+27.4%+21.7%+21.3%+4.4%---
EBITDA CAGR (3Y)+67.5%+138.1%+72.7%+14.5%---
Profitability & leverage
Net income margin+16.2%+16.1%+16.0%+5.3%-1.9%+1.5%+2.2%
Return on capital employed-+27.6%+39.2%+17.6%+2.6%+9.0%+10.6%
Return on net worth-+25.8%+47.6%+16.4%-5.8%+3.4%+5.9%
Debt / equity-0.390.680.650.610.580.61
Long-term debt / equity-0.210.300.300.290.310.34
Interest cover12.9511.749.5628.65216.6759.1245.64
Efficiency & per share
Fixed asset turnover-1.371.471.371.451.211.47
Inventory turnover-10.8529.0395.3836.5315.1614.19
Debtors turnover-4.865.295.766.485.216.77
EPS (₹)10.088.508.012.02(0.69)0.410.71
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0049.3720.3313.3311.3012.4711.98

Competitors of Chandan Diagnostic

Chandan Diagnostic has 3 listed competitors in our database, 2 of them funded. They include Thyrocare, Vijaya Diagnostic Centre and Suraksha Diagnostics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Thyrocare
thyrocare.com1996Mumbai, India$63.59M1,889
Diagnostic testing centers for pathology and health screenings are operated.
Vijaya Diagnostic Centre
vijayadiagnostic.com1981Hyderabad, India
Diagnostic services are offered via a chain of centers.
Suraksha Diagnostics
surakshanet.com2005Kolkata, India$49M1,180
Pathology, molecular diagnostics, and imaging services are provided.
Premium access

Detailed competitors of Chandan Diagnostic

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Chandan Diagnostic

The website of Chandan Diagnostic (chandandiagnostic.com) receives about 11.1K visits a month.

  • Monthly visits
    11.1K

    ▼ 19.7% vs previous month

Similar websites

Websites whose visitors overlap most with Chandan Diagnostic. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Chandan Group
chandan.co.in
100%
#3,332,420View details

Top companies in Diagnostics Laboratories

3 companies that operate in the same segment as Chandan Diagnostic (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Thyrocare
Diagnostic testing centers for pathology and health screenings are operated.
1996Mumbai, Maharashtra, IndiaUSD 63.59 MUSD 88.36 M1,950
Dr Lal PathLabs
Chain of pathology and radiology labs
1949Gurugram, Haryana, IndiaUSD 13.9 MUSD 294.49 M5,310
Redcliffe Labs
Home-based diagnostic tests are booked via an online platform.
2018Noida, Uttar Pradesh, IndiaUSD 116.42 MUSD 41.86 M2,308
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Chandan Diagnostic

Chandan Healthcare Acquires Two Ansh Diagnostics Units In Ghaziabad – Outlook Business
Outlook Business • 23 days ago
Chandan Healthcare Scales Franchise Network To 500+ Franchises; Targets 1,000 Franchises By FY27-End – Outlook Business
Outlook Business • 1 month ago
Chandan Healthcare consolidated net profit rises 29.53% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 2 months ago
Chandan Healthcare Ltd Buys Nishkam Imaging In New Delhi
Reuters • 6 months ago
Chandan Healthcare Ltd Secures Tender For 1.5 Tesla MRI System At Civil Hospital Rohtak
Reuters • 7 months ago
Chandan Healthcare Commenced Diagnostic Operations In Kota, Rajasthan
Reuters • 7 months ago
Chandan Healthcare Says Awarded 10-Year PPP Project In Punjab
Reuters • 7 months ago
Chandan Healthcare Ltd Awarded 10-Year PPP Project In Punjab
Reuters • 9 months ago
Chandan Healthcare Starts Diagnostic Operations In Punjab
Reuters • 9 months ago
Chandan Healthcare Gets Project Worth 260 Million Rupees
Reuters • 10 months ago
Premium access

Complete news archive for Chandan Diagnostic

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Diagnostic

Chandan Diagnostic was founded in 1991.

Chandan Diagnostic is headquartered in Lucknow, India. It is registered at Lucknow, Uttar Pradesh, India.

The primary company behind Chandan Diagnostic, Chandan Healthcare Limited, reported revenue of ₹281 Cr for FY 2026, up 20% year on year.

Chandan Diagnostic was established in 1991 in Lucknow, India, within the healthcare sector. A network of laboratory centers is maintained, focusing on radiology and pathology services. Diagnostic testing and imaging procedures are provided to patients across multiple locations in the region. Operations are centered on clinical laboratory functions, supporting medical diagnostics for local communities. The domain chandandiagnostic.com is utilized for online presence and information dissemination.

Chandan Diagnostic's top competitors include Thyrocare, Suraksha Diagnostics and Vijaya Diagnostic Centre.

Chandan Diagnostic offers Diagnostic Tests, Home Sample Collection, and Mobile App Booking.

Yes, Chandan Diagnostic is publicly traded on NSE under the ticker symbol CHANDAN.

Chandan Diagnostic operates through Chandan Healthcare Limited.

The legal entities of Chandan Diagnostic currently have 8 directors, including Amar Singh, Asmita Singh, Vinay Lamba and others.

Yes. Chandan Diagnostic publishes Chandan 24x7, with over 100,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available